David R. Epstein - 19 May 2022 Form 4 Insider Report for Axcella Health Inc.

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 19 May 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jun 2022, 16:30:55 UTC
Prior SEC filing: 13 May 2022
Next SEC filing: 31 May 2022
Source filing: View source filing
Reporting owner signature: By: /s/ William Hinshaw, Attorney-in-Fact

Key filing fact

David R. Epstein filed Form 4 for Axcella Health Inc. on 03 Jun 2022.

Key facts

This page summarizes David R. Epstein's Form 4 filing for Axcella Health Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2022, 16:30.

Change

Previous filing in this sequence was filed on 13 May 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AXLA transaction

Common Stock

Award

Transaction value: $0
Shares: +47,059
Change %: +29%
Price: $0.000000
Shares after: 209,756
Date: 19 May 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents a grant of 47,059 restricted stock units ("RSUs"), each representing a contingent right to receive one share of AXLA common stock. The shares underlying this grant shall vest in twelve equal monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.